Search Results

You are looking at 21 - 30 of 947 items for :

  • Refine by access: All content x
Clear All
Marie Plourde Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Marie Plourde in
Google Scholar
PubMed
Close
,
Caroline Manhes Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Caroline Manhes in
Google Scholar
PubMed
Close
,
Gilles Leblanc Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Gilles Leblanc in
Google Scholar
PubMed
Close
,
Francine Durocher Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Francine Durocher in
Google Scholar
PubMed
Close
,
Martine Dumont Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Martine Dumont in
Google Scholar
PubMed
Close
,
Olga Sinilnikova Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Olga Sinilnikova in
Google Scholar
PubMed
Close
,
INHERIT BRCAs
Search for other papers by INHERIT BRCAs in
Google Scholar
PubMed
Close
, and
Jacques Simard Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada
Cancer Genomics Laboratory, Plate-Forme Mixte de Génétique Constitutionnelle des Cancers Fréquents, Canada Research Chair in Oncogenetics, Oncology and Molecular Endocrinology Research Center, Centre Hospitalier Universitaire de Québec and Laval University, Quebec G1V 4G2, Canada

Search for other papers by Jacques Simard in
Google Scholar
PubMed
Close

Introduction Most of the familial aggregation in breast cancer results predominantly from inherited susceptibility ( Lichtenstein et al . 2000 , Peto & Mack 2000 ). Germline mutations in high-penetrance cancer susceptibility genes such as breast

Free access
Ankita Agrawal Department of Human Metabolism, The Mellanby Centre for Bone Research, The University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK

Search for other papers by Ankita Agrawal in
Google Scholar
PubMed
Close
and
Alison Gartland Department of Human Metabolism, The Mellanby Centre for Bone Research, The University of Sheffield, Beech Hill Road, Sheffield S10 2RX, UK

Search for other papers by Alison Gartland in
Google Scholar
PubMed
Close

people at a greater risk of developing diseases and bone disorders. P2X7R and bone cancer Bone tissue provides a fertile setting for cancer cells and is a common metastatic site owing to this microenvironment. Signalling mechanisms involving purines and

Free access
F M Fioretti Androgen Signalling Laboratory, Molecular Oncology, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK

Search for other papers by F M Fioretti in
Google Scholar
PubMed
Close
,
A Sita-Lumsden Androgen Signalling Laboratory, Molecular Oncology, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK

Search for other papers by A Sita-Lumsden in
Google Scholar
PubMed
Close
,
C L Bevan Androgen Signalling Laboratory, Molecular Oncology, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK

Search for other papers by C L Bevan in
Google Scholar
PubMed
Close
, and
G N Brooke Androgen Signalling Laboratory, Molecular Oncology, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK
Androgen Signalling Laboratory, Molecular Oncology, Department of Surgery and Cancer, Imperial College London, London W12 0NN, UK

Search for other papers by G N Brooke in
Google Scholar
PubMed
Close

Breast cancer Breast cancers (BCs) account for one in three newly diagnosed cases of cancer in women and led to 11 600 deaths in 2010 in the UK alone ( CRUK 2014 ). Incidence rates increased by 90% between 1971 and 2010, with the largest increase in

Free access
Irene I Lee Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Irene I Lee in
Google Scholar
PubMed
Close
,
Nane C Kuznik Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Eggenstein-Leopoldshafen, Germany

Search for other papers by Nane C Kuznik in
Google Scholar
PubMed
Close
,
Jaice T Rottenberg Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Jaice T Rottenberg in
Google Scholar
PubMed
Close
,
Myles Brown Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA
Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA

Search for other papers by Myles Brown in
Google Scholar
PubMed
Close
, and
Andrew C B Cato Karlsruhe Institute of Technology, Institute of Toxicology and Genetics, Eggenstein-Leopoldshafen, Germany

Search for other papers by Andrew C B Cato in
Google Scholar
PubMed
Close

experimentally tested. BAG1L and prostate cancer The regulation of AR activity by BAG1L and the driver role of the AR in prostate cancer progression has generated an interest in the action of BAG1L in prostate cancer. A link between BAG1L and prostate

Free access
Cathrin Brisken ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Station 19, Lausanne, Switzerland
Breast Cancer Now Research Centre, Institute of Cancer Research, London, UK

Search for other papers by Cathrin Brisken in
Google Scholar
PubMed
Close
and
Valentina Scabia ISREC - Swiss Institute for Experimental Cancer Research, School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne (EPFL), Station 19, Lausanne, Switzerland

Search for other papers by Valentina Scabia in
Google Scholar
PubMed
Close

Introduction A woman’s risk to get breast cancer is affected by her reproductive history and hence exposure to reproductive hormones. An early full-term pregnancy has protective effects ( MacMahon et al. , 1970 ), whereas risk increases with

Free access
Dagmara Rusinek Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska‐Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland

Search for other papers by Dagmara Rusinek in
Google Scholar
PubMed
Close
,
Sylwia Szpak-Ulczok Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska‐Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland

Search for other papers by Sylwia Szpak-Ulczok in
Google Scholar
PubMed
Close
, and
Barbara Jarzab Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska‐Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44-101 Gliwice, Poland

Search for other papers by Barbara Jarzab in
Google Scholar
PubMed
Close

Introduction Gene expression profiling of thyroid tumors has expanded our knowledge of the molecular biology of thyroid cancer. Several recent reviews addressed the biological and diagnostic aspects of microarray-based studies of thyroid cancer

Free access
Ali Salajegheh Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia

Search for other papers by Ali Salajegheh in
Google Scholar
PubMed
Close
,
Haleh Vosgha Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia

Search for other papers by Haleh Vosgha in
Google Scholar
PubMed
Close
,
Atiqur Md Rahman Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia

Search for other papers by Atiqur Md Rahman in
Google Scholar
PubMed
Close
,
Moein Amin Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia

Search for other papers by Moein Amin in
Google Scholar
PubMed
Close
,
Robert Anthony Smith Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia
Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia

Search for other papers by Robert Anthony Smith in
Google Scholar
PubMed
Close
, and
Alfred King-Yin Lam Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia
Cancer Molecular Pathology, Faculty of Health, Pathology Queensland and Gold Coast University Hospital, School of Medicine, Griffith Medical School, Menzies Health Institute Queensland, Gold Coast Campus, Gold Coast, Queensland 4222, Australia

Search for other papers by Alfred King-Yin Lam in
Google Scholar
PubMed
Close

-205 can repress cancer proliferation, clonogenic survival, growth and aggressiveness by direct targeting of related genes such as E2F1 and BCl2 ( Vosgha et al . 2014 ). Nonetheless, the role of this miRNA has not been investigated in the

Free access
James F H Pittaway Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Search for other papers by James F H Pittaway in
Google Scholar
PubMed
Close
and
Leonardo Guasti Centre for Endocrinology, William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London, UK

Search for other papers by Leonardo Guasti in
Google Scholar
PubMed
Close

expression maintains an undifferentiated phenotype and promotes clonogenicity, findings suggestive of cancer stem cell-like functionality ( Kim et al. 2009 ). In the rat adrenal cortex, Dlk1 is co-expressed with Shh cells in the ZU ( Guasti et al. 2013

Free access
Amy R Dwyer Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Amy R Dwyer in
Google Scholar
PubMed
Close
,
Thu H Truong Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Thu H Truong in
Google Scholar
PubMed
Close
,
Julie H Ostrander Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Julie H Ostrander in
Google Scholar
PubMed
Close
, and
Carol A Lange Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, USA
Department of Medicine, Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA
Department of Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA

Search for other papers by Carol A Lange in
Google Scholar
PubMed
Close

cancer subtypes. However, increasing studies have implicated differential PR isoform expression in the etiology of breast cancer ( Mote et al. 2002 , 2015 , Rojas et al. 2017 , Lamb et al. 2018 ). Furthermore, PRs dramatically influence ER

Free access
Adrien Georges CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France

Search for other papers by Adrien Georges in
Google Scholar
PubMed
Close
,
Aurelie Auguste CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France

Search for other papers by Aurelie Auguste in
Google Scholar
PubMed
Close
,
Laurianne Bessière CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France

Search for other papers by Laurianne Bessière in
Google Scholar
PubMed
Close
,
Anne Vanet CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France

Search for other papers by Anne Vanet in
Google Scholar
PubMed
Close
,
Anne-Laure Todeschini CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France

Search for other papers by Anne-Laure Todeschini in
Google Scholar
PubMed
Close
, and
Reiner A Veitia CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France
CNRS UMR 7592, Université Paris Diderot, Institut Jacques Monod, 15 Rue Hélène Brion, 75013 Paris, France

Search for other papers by Reiner A Veitia in
Google Scholar
PubMed
Close

role in late folliculogenesis. For example, FOXL2 overexpression in GCT-derived cells causes induction of prostaglandin synthase (or COX2), but it has also been showed that it could repress the induction of this gene by ESR1 in breast cancer or

Free access